Search Weight Loss Topics:

Page 78«..1020..77787980..90100..»

Home » Testosterone » Page 78

Global Endocrinology Drugs Market 2020-2024 The analyst has been monitoring the global endocrinology drugs market and it is poised to grow by USD 24. 78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period.

New York, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Endocrinology Drugs Market 2020-2024" - https://www.reportlinker.com/p03793964/?utm_source=GNW Our reports on global endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in incidence of endocrine disorders. In addition, association between obesity and endocrine disorders is anticipated to boost the growth of the global endocrinology drugs market as well.

Market Segmentation The global endocrinology drugs market is segmented as below: Therapy area Diabetes Drugs Thyroid Hormone Disorder Drugs HGH Testosterone Replacement Therapy Others

Geographic segmentation North America Europe Asia ROW

Key Trends for global endocrinology drugs market growth This study identifies association between obesity and endocrine disorders as the prime reasons driving the global endocrinology drugs market growth during the next few years. Prominent vendors in global endocrinology drugs market We provide a detailed analysis of around 25 vendors operating in the global endocrinology drugs market, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Eli Lilly and Co., GlaxoSmithKline Plc, Groupe Sanofi, Merck & Co. Inc., Novartis International AG, Novo Nordisk AS and Pfizer Inc. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.Read the full report: https://www.reportlinker.com/p03793964/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

More:
The Global Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period -...

Teens with obesity and polycystic ovary syndrome (PCOS) have decreased bacterial diversity and a more "unhealthy" gut microbiome compared to similar-sized teens without PCOS, according to a new study published online January 23 in the Journal of Clinical Endocrinology & Metabolism.

"We have for the first time demonstrated that obese adolescents with PCOS have an altered gut microbiome compared to girls without PCOS with similar body mass index (BMI), activity level, and dietary habits," write Beza Jobira, MD, and colleagues.

Jobira is affiliated with Children's Hospital Colorado, Anschutz Medical Campus, in Aurora.

Researchers also observed that higher testosterone levels, which are often found in women with PCOS, were linked to decreased bacterial diversity in the gut.

"The unhealthy bacteria [were] related to higher testosterone concentrations and markers of metabolic complications. The gut microbiome may play a role in PCOS and its related metabolic complications, and these changes can be found in teenagers who are early in the course of the condition," senior author Melanie Cree-Green, MD, PhD, also of Children's Hospital Colorado, said in a press release issued by The Endocrine Society.

"Further work is needed to better understand the relationship between androgens and the microbiome, especially as a potentially new avenue for therapy," the authors write.

PCOS affects about 6%-18% of women worldwide but is more common among teenagers who are obese and typically starts in adolescence. Individuals affected by the hormonal condition show a range of symptoms, including acne, excess body hair, and irregular periods.

The condition is linked to increased risk for cardiometabolic conditions including type 2 diabetes and cardiovascular disease, as well as nonalcoholic fatty liver disease (NAFLD), infertility, and depression.

"Despite the increased risk of obesity and metabolic syndrome in women with PCOS, there are limited data linking altered gut microbiota to PCOS," the researchers say.

"Our goal was thus to determine if youth with PCOS and obesity have altered composition of gut microbiota compared to equally obese girls with regular menstrual cycles. This information could provide additional directions to improve treatment and prevention of PCOS," they write.

To study the issue, they conducted a prospective, case-control, cross-sectional study that included 58 teens who were obese and sedentary with an average age of 16 years. Participants were from pediatric endocrinology and lifestyle medicine outpatient clinics at the Children's Hospital Colorado.

The teenagers self-reported dietary and physical activity on standardized questionnaires. Laboratory tests included fasting glucose, sex hormone levels, alanine aminotransferase (ALT, a measure of liver function), inflammatory markers, and lipid levels. Researchers analyzed stool samples for bacterial genetic material.

Compared to participants without PCOS (n = 21), teens with PCOS (n = 37) had significantly decreased -diversity, a measure of bacterial diversity within each individual participant (Shannon diversity, P = .045 and evenness, P = .0052).

"By closely matching our control and PCOS groups for BMI z score, which is a measure that is adjusted for age, as well as having a very similar absolute BMI, we were able to detect differences based on disease status without the confounder of weight," the researchers observe.

The PCOS group also had significantly decreased -diversity, a comparison of overall bacterial composition between the two groups (P < .001).

Results also showed a higher percentage relative abundance (%RA) of phyla Actinobacteria (P = .027), lower Bacteroidetes (P = .004), and similar Firmicutes and Proteobacteria in the PCOS group compared with the non-PCOS group.

These four types of bacteria make up the majority of the gut microbiome, the researchers explain.

Changes in the relative abundance of these bacteria have been linked to a high-fat, low-fiber diet, as well as conditions associated with PCOS, including obesity, insulin resistance, type 2 diabetes, NAFLD, and inflammation in general.

In this study, lower Bacteroidetes was linked to a 4.4 increased likelihood of having PCOS.

Laboratory tests also showed that higher testosterone levels were significantly associated with decreased -diversity (P < .001).

A range of bacteria were linked to markers of metabolic syndrome, such as waist-to-hip ratio, fasting triglycerides, fasting insulin, and insulin sensitivity.

The study had several limitations. Not all lab tests were available for all participants because they came from three different studies with varying study designs. The study was relatively small, took place at a single tertiary care center, and did not include normal weight individuals with PCOS.

The study was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, Doris Duke Foundation, Boettcher Foundation Webb-Waring award, University of Colorado GI and Liver Innate Immune Program, Center for Women's Health Research, and National Institutes of Health/National Center for Advancing Translational Sciences. The authors have reported no relevant financial relationships.

J Clinical Endocrinol & Metabol. Published online January 23, 2020. Abstract

For more diabetes and endocrinology news, follow us on Twitter and Facebook.

Original post:
Gut Microbiome Is Less Diverse in Teens With Obesity and PCOS - Medscape

Global Testosterone Replacement Therapy Market Report assistances industry leaders to make confident capital investment decisions, develop strategic plans, optimize their business portfolio, innovate successfully and operate safely and sustainably. The report also offers a detailed summary of the industry including definitions, classifications, growth factors, applications and market chain structure, revenue development in terms of volume with respect to the Testosterone Replacement Therapy Market.

The report also embraces the absolute growth revenue value of the Testosterone Replacement Therapy Market across the globe over the forecast period 2020-2027. The Testosterone Replacement Therapy Market is anticipated to surpass more than US$ xxx million by 2027 at a CAGR of xx% in the given forecast period.

Get Sample Copy of this Report@: https://www.healthcareintelligencemarkets.com/request_sample.php?id=135698

Top Key Players Profiled in This Report: AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Testosterone Replacement Therapy Market report is the reliable source for obtaining the market study which will rapidly expand your business. A separate analysis of prevailing trends within the parent market and rules and mandates is enclosed underneath the ambit of the study. So, the report comes the attractiveness of every major section over the forecast amount.

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Key Findings of the Global Testosterone Replacement Therapy Market:

What will the market size and the growth rate be in 2027?

What are the key factors driving the Global Testosterone Replacement Therapy Market?

What are the key market trends impacting the growth of the market?

What are the challenges to market growth?

Who are the key vendors in the Global Testosterone Replacement Therapy Market?

What are the market opportunities and threats faced by the vendors in this market?

Get Attractive Discount on This Report@: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=135698

This research report represents a 360-degree overview of the competitive landscape of the Testosterone Replacement Therapy Market. Furthermore, it offers massive data relating to recent trends, technological advancements, tools, and methodologies. The research report analyzes the Testosterone Replacement Therapy Market in a detailed and concise manner for better insights into the businesses.

Major Factors:

1. Global Testosterone Replacement Therapy Market Overview

2. Economic Impact on Industry

3. Market Competition by Manufacturers

4. Production, Revenue (Value) by Region

5. Supply (Production), Consumption, Export, Import by Regions

6. Production, Revenue (Value), Price Trend by Type

7. Market Analysis by Application

8. Manufacturing Cost Analysis

9. Industrial Chain, Sourcing Strategy and Downstream Buyers

10. Marketing Strategy Analysis, Distributors/Traders

11. Market Effect Factors Analysis

12. Global Testosterone Replacement Therapy Market Forecast

Place a Direct Order Of this Report: https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=135698

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

HealthCare Intelligence Markets:

HealthCare Intelligence Markets Reports provides market intelligence & consulting services to a global clientele spread over 145 countries. Being a B2B firm, we help businesses to meet the challenges of an ever-evolving market with unbridled confidence. We craft customized and syndicated market research reports that help market players to build game-changing strategies. Besides, we also provide upcoming trends & future market prospects in our reports pertaining to Drug development, Clinical & healthcare IT industries.

Contact us:

Marvella Lit

Phone No.: +1 (888) 616-2766

Address: 90 State Office Center

90 State Street Suite 700, Albany, NY 12207

sales@healthcareintelligencemarkets.com

http://www.healthcareintelligencemarkets.com

Original post:
Testosterone Replacement Therapy Market 2020-2027 is booming in forthcoming year by Leading Players AbbVie - Briotainment

The Testosterone Replacement Therapy Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Testosterone Replacement Therapy market report provides authentic and reliable estimates for the forecast period.

It became essential to distinguish the saturation of consumption in the Testosterone Replacement Therapy market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation analysis based on several segments such as types, applications, regions, and end-users. It serves to precise target the actual market size and product and service needs of customers. It also helps industry companies in promoting products that completely meet emerging customer needs.

Collect sample copy of the Testosterone Replacement Therapy market research at: https://www.amplemarketreports.com/sample-request/global-testosterone-replacement-therapy-market-1308418.html

The report furnishes the analysis of market encounter, segmentation, leading market players, industry environment, and microeconomic factors that help clients, Testosterone Replacement Therapy companies, investors, officials, and researchers perceive ongoing market performance within a minute. The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting factors, and market variations that have been considered the most important factors in the Testosterone Replacement Therapy market.

Comprehensive analysis of Testosterone Replacement Therapy market segment by manufactures:

The report also highlights its financial position by assessing gross margin, profitability, production cost, pricing structure, expenses, Testosterone Replacement Therapy sales volume, revenue, and growth rate. Their raw material sourcing strategies, organizational structure, corporate alliance, Testosterone Replacement Therapy production volume, manufacturing base, sales areas, distribution network, global presence, product specifications, effective technologies, major vendors, and import-export activities are also emphasized in this report.

The report includes profound importance for the individuals/companies operating and financing in the Testosterone Replacement Therapy market as AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, it holds helpful insights that immediate to discover and interpret market demand, market size, share, and rivalry sitch. The report incorporates comprehensive market intelligence procured using both qualitative and quantitative research methods. It also contracts proficient systematic analytical studies including Porters Five Forces, SWOT analysis, and Probability analysis to review the market thoroughly.

Find out more about competitive landscape at: https://www.amplemarketreports.com/report/global-testosterone-replacement-therapy-market-1308418.html

The report moreover presents a comprehensive representation of Testosterone Replacement Therapy manufacturers and companies who have been attempting to pose their dominance in the market in terms of sales, revenue, and growth. The report traverses their applications such as product research, development, innovation, and technology appropriation which supports them deliver more efficient product lineup in the industry. Profitable business plans, including acquiring, mergers, ventures, amalgamations, as well as product launches, and brand promotions are also elucidating in the report.

Comprehensive analysis of Testosterone Replacement Therapy market segment Type, Application:

Furthermore, it explores various requisite segments of the global Testosterone Replacement Therapy market such as types, applications, regions, and technologies. The report grants a comprehensive analysis of each market acknowledging market acceptance, attractiveness, demand, production, and predicted sales revenue by Type(Gels, Injections, Patches, Other) and by Application(Hospitals, Clinics, Others). The segmentation analysis helps consumers to select suitable segments for their Testosterone Replacement Therapy business and specifically target the wants and needs of their existing and potential customer base.

Comprehensive analysis of Testosterone Replacement Therapy market segment by Regional Anlaysis:

The report focuses on regional coverage across the globe principally with respect to x-x Units, revenue (Million USD), market share and growth rate variable with in each region depending upon its capacity. Regions that have been covered for this market included Asia-Pacific, Europe, North America, Middle East & Africa, South America

Discount, Know more this research report at: https://www.amplemarketreports.com/discount-request/global-testosterone-replacement-therapy-market-1308418.html

Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Western / Eastern Europe or Southeast Asia.

With the given market data, Research on Global Markets offers customizations according to specific needs. Write to AMR at sales@amplemarketreports.com, or connect via +1-530-868-6979

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to delivery reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: sales@amplemarketreports.com

https://www.amplemarketreports.com

Follow this link:
Testosterone Replacement Therapy Market is Estimated to Grow at the Highest Growth Rate till 2020-2024 - Expedition 99

If you have a confirmed testosterone deficiency, its important to identify if there are any reversible causes that can be addressed before committing to, what should be considered a lifelong therapy. Testosterone Replacement Therapy (TRT) is an involved process. In my professional opinion, the most effective method of replacement is daily Testosterone Cypionate and Human Chorionic Gonadotropin (HCG) injections. Your dose is carefully titrated to normalise your male androgen levels.

TRT is an involved process, its a financial commitment and its a time-consuming process. Two daily subcutaneous injections, admittedly with a tiny 29-gauge insulin needle, preparation of your multi-dose vial, every 3 months for Testosterone Cypionate and monthly for HCG, regular blood tests, additional blood tests after a protocol change. We have patients from all over the UK, Europe and further afield, they all have an initial face to face consultation and yearly thereafter, the rest can be managed remotely. Some of my patients travel thousands of miles, Denmark, Norway, Spain, Portugal, Dubai, the Philippines to ensure they receive Gold Standard care. Londoners often complain a trip to Poole is too far, little do they know.

TRT has traditionally been thought of as simply replacing the testosterone. It makes sense, replace the testosterone that is deficient. The issue lies with the subsequent negative effect on other important parameters administration of exogenous testosterone has on the body. Injecting testosterone shuts down the Hypo-pituitary Gonadal (HPG) axis, you know longer produce Lutenising Hormone (LH) and Follicle Stimulating Hormone (FSH) from the pituitary gland in the brain. LH stimulates the Leydig cells of the testes to produce testosterone, the FSH stimulates the Sertoli cells to produce sperm through a process called spermatogenesis.

HCG mimics LH, it is used in the treatment of male infertility. Intra-testicular testosterone is partly converted to oestradiol by the aromatase enzyme, this helps facilitate spermatogenesis. The Mens Health Clinic now has 20 pregnancies with the concurrent use of HCG alongside testosterone. Its important to appreciate that there are LH receptors all over the body, most noticeably the brain. HCG is clearly important to help maintain fertility and testicular size, but its effects are more wide ranging. Men report an improved sense of well-being and libido using HCG alongside testosterone.

I am uncomfortable with allowing an organ, in this case your testicles, to atrophy with testosterone monotherapy. It seems illogical to me that this should be accepted. I believe that irrespective of whether you want to conceive or not, you should replace this hormone. TRT should be considered hormone replacement therapy (HRT), we should be maintaining function with HCG and supplementing with testosterone to ensure your male androgen levels are normalised.

I am rather shocked and appalled that the medical community has such a simplistic approach to TRT, as one NHS Endocrinologist recently said to me either the patient wants to retain fertility in which case you offer HCG or they do not want to retain fertility in which case you treat with testosterone. This regressive and outdated attitude and approach to TRT is one of the reasons men are willing to travel from all over the world to The Mens Health Clinic, Gold Standard care.

Read this article:
Testosterone Replacement Therapy or Hormone Replacement Therapy? - Reno Hotline

Q: A recent news release suggested that men with low testosterone levels may have improvement in sexual function and quality of life. How can I determine whether I can benefit and what questions should I ask my doctor?

A: Before we get into the details of the newly reported benefits of testosterone therapy including the scope of those benefits and the men most likely to see them lets talk about what, exactly, testosterone is, what it does, and what constitutes low levels (also sometimes referred to as low T, andropause, or even male menopause).

To start with, testosterone is the most important male hormone (although women have measurable levels as well). In a nutshell, its what makes men men at least physically. Its manufactured in the testicles and plays a significant role in puberty (including penis and testicle growth and voice deepening), muscle and bone growth and development, strength, sex drive, and fertility.

Testosterone levels are usually measured with a blood test and are reported in terms of nanograms per deciliter (abbreviated as ng/dL). The normal range for men 20-70 is 300-1000 ng/dL. However, starting at about age 30, mens levels gradually decrease by an average of 1-2% per year. According to the journal Annals of Internal Medicine, the symptoms of low testosterone include little or no interest in sex, erectile dysfunction, less energy/feeling weak, mood changes and feeling depressed, loss of bone mineral density, and loss of body and facial hair. However, there is significant debate as to whether these symptoms are truly associated with low testosterone or if they are a result of other factors, such as chronic illness or certain medications.

Studies have found that 20%-40% of males ages 30-70 have low testosterone levels (although its important to note that not all of them will have any negative symptoms).

Okay, now lets talk about the news stories you may have heard about. The study in question evaluated 38 other high-quality studies and focused on men with age-related low testosterone and the effects of testosterone replacement therapy (TRT). The findings were fairly limited: Overall, men who received TRT experienced small improvements in sexual function and quality of life. The researchers did not find that TRT offered any benefits for other age-related issues, such as lack of energy, mood, strength, memory, or cognitive ability. And they were unable to shed any new light on any of the previously reported links between testosterone replacement therapy and heart health, prostate cancer, or mortality.

So, what should you do if you think you might have age-related low testosterone? The Washington DC-based non-profit, Mens Health Network (menshealthnetwork.org), recommends that you discuss your symptoms with your doctor and ask for a blood test. If your levels come back low, you should ask your doctor the following questions recommended by the American College of Physicians (ACP): Will taking TRT help with the symptoms that I came to discuss with you? What method of TRT is best for me? What are the risks and side effects of treatment? And How long will it take for TRT to work, and what if it does not work?

Mens Health Network supports the ACPs guidelines, which recommend that doctors consider offering TRT via intramuscular injection rather than a patch, gel, or pellet. The ACP believes that injections are cheaper, yet just as effective as other methods and involve similar side effects. However, they recognize that injections (which will need to happen every 1-4 weeks) may not be for everyone.

Armin Brott is the author of Blueprint for Mens Health, Your Head: An Owners Manual, and many other works on mens health. Visit him at HealthyMenToday.com.

Go here to read the rest:
Healthy Men: Benefits of male hormone replacement therapy - Duluth News Tribune

ANDOR BUJDOSO
Getty Images

A boutique London gym chain, GYMBOX, has come under fire for its response to a female member, who complained after a male acted aggressively towards her on the gym floor. The clincher? The GYMBOX staff member who replied to her email put it down to the man having "high levels of testosterone" after exercising. Umm, what?

Taking to Twitter to air the email reply she received, Elena Banbury explained the situation to her followers, by saying, "So a random gym goer harassed me and my friend at our first visit to @GYMBOXofficial, this is the response we got... Glad to see staff justifying aggressive behaviour because its never happened to them, and men have testosterone...".

Elena also posted the initial email she sent to GYMBOX, explaining that the man had called her "pathetic" for the way she was using a leg press machine and threw weights on the floor, then continued staring at her.

The reply to her from GYMBOX read:

Hi Elena,

Apologies but I never got your first email.

It is unfortunate you had such an experience in our gym, I have never had similar issues with members. I understand that what was said was inappropriate and rude. I have been working in this gym for 3 years and I haven't had any complaints about [name erased].

I will bring this up with my manager and have a discussion with him.

Obviously this isn't a great start, but things then took an even worse turn:

From my personal point of view, it is an unfortunate situation where a guy was rude to you, but it could have happened anywhere. We are in a gym where testosterone levels are high, especially during workouts. This means that reactions to situations can be a bit extreme, especially for men.

Wow.

When we contacted GYMBOX for comment, they responded saying they'd investigate the incident and admitted that the response to the complaint has "fallen short of what it should be" (err, yeah, ya think?):

Like this article? Sign up to our newsletter to get more articles like this delivered straight to your inbox.

SIGN UP

Follow Jennifer on Instagram and Twitter

See original here:
This gym just gave the worst response to harassment - cosmopolitan.com

The female birth control pill has been around for about 60 years now. Prescribed by a doctor and taken daily, it is highly effective in preventing pregnancies (99.7% effective with perfect use). At the same time, not much progress has been made in manufacturing a male contraceptive pill. There are two methods used by men currently: condoms are the most common, with very few men opting for vasectomies. The latter is reversible now (though there is no guarantee of conception); a surgery in which the vas deferens, which transfers sperm to the urethra, is cut or tied.

Representational image. Image source: Getty Images.

Why is there no male contraceptive pill? Opinion polls have suggested reluctance in its usage and many pharmaceutical companies may have not thought of it as a worthwhile investment. It appears that there just isnt enough demand for it. Considering that there are 89 million unintended pregnancies and 48 million abortions a year, this is rather surprising.

Pills or injections that have been developed for men have produced undesirable side effects. A commonly used method is to lower the amount of testosterone in the body to suppress the production of sperm - but if the level of testosterone falls too low there is a higher likelihood of mood disorders and depression. Participants in pilot stages also reported lower libido and temporary erectile dysfunction.

Last year, a drug was developed that contained progestin and modified testosterone. The progestin works to lower sperm production and the modified testosterone helps maintain the levels of testosterone in the body. This drug, in small clinical trials, performed well, but the above mentioned side effects were still present. The researchers said that further study was required and that it would be a decade before the drug could become reality.

Researchers at the University of Dundee in Scotland have developed an unrivalled, fully automated robotic screening system which allows them to check the effectiveness of chemicals on sperm in real-time. The technology allowed them to study 13,000 drugs that were in the clinical trial stage at the cellular level and analyze their effectiveness. In a breakthrough, the researchers revealed that it is possible to find effective agents that halt sperm in its tracks and further research will be carried out on these chemicals.

So far, our understanding of the biology of sperm has been surprisingly limited. We do not have sufficient knowledge of protein targets that make sperm act the way they do. Further, technological constraints have meant that researchers are unable to test the interactions of multiple chemicals with sperm, and clinical trials that have been conducted or are in process are very slow. By building a miniaturized parallel testing agent and image processing tools, these shortcomings have been overcome. Also, an interaction known as the acrosome reaction can be examined from a different lens thanks to technology. This reaction is a critical part of fertilization and understanding its mechanics will further our understanding of how sperm works.

The advent of robot technology could mean that we are finally closer to a male contraceptive pill or injection. This should, hopefully, lead to a decrease in the number of unintended pregnancies.

For more information, read our article onBirth Control Methods.

Health articles in Firstpost are written by myUpchar.com, Indias first and biggest resource for verified medical information. At myUpchar, researchers and journalists work with doctors to bring you information on all things health.

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

Read more here:
Researchers are one step closer to developing a safe and effective male contraceptive pill - Firstpost

Christy Florence, the wife of a transgender man and mother of a trans daughter, wrote an open letter to her brother, a conservative lawmaker in Utah, decrying his reported efforts to introduce legislation that would restrict transgender health care for minors in the state.

"Brad, I implore you to leave the decisions of medical care to the parents and medical professionals," she wrote in The Salt Lake Tribune to her brother, state House Rep. Brad Daw, a Republican. "Trust the experts. They know what they are doing. These families know their children and what is the very best for them."

While the anticipated legislation has not yet been proposed, The Tribune reported this month that Daw had begun drafting a bill to ban gender reassignment operations and the use of cross-sex hormones for trans minors. Similar measures have been introduced in at least seven other states this month.

The Morning Rundown

Let our news meet your inbox. The news and stories that matters, delivered weekday mornings.

Daw declined NBC News' request for comment.

Florence, co-founder of the Utah LGBTQ advocacy group Mama Dragons, said in her op-ed that she has sat with many transgender young people and their families and "listened to their struggles." She said transgender health care is "life-saving" and those seeking it often face "insurmountable obstacles." The bill her brother is reportedly about to propose, she added, would "restrict survival opportunities for young people who are transgender."

The Tribune reported that Daw is writing the draft legislation following a request by the conservative Eagle Forum, founded by the activist Phyllis Schlafly.

"We want to do what we think is reasonable practice, which is put off that kind of one-way ticket decision until the youth is an adult," Daw told the paper.

According to local media, Daw's bill is being framed as a compromise, at least compared to bills progressing in legislatures in states like Tennessee and South Dakota, because it would not restrict the use of puberty blockers, which a study published last week found to be linked to lower suicide risk for trans people.

But experts warned that even a less draconian effort than Utah's which would permit the use of puberty blockers but not cross-sex hormones could have unintended consequences.

"Puberty blockers are an important component of care for transgender youth; however, they are insufficient on their own," said Dr. Jack Turban, a resident psychiatrist at Harvard Medical School and lead author of the puberty study. "Guidelines set forth by major medical organizations, including the Endocrine Society, explain that hormonal treatments like estrogen and testosterone are also needed."

Without cross-sex hormones like estrogen and testosterone, Turban added, trans adolescents who wish to suppress puberty may not see proper bone development. Turban also noted that genital surgery for minors, which would reportedly be banned in Daw's bill, already goes against existing medical guidelines.

"At the end of the day, legislators should not pick away individual steps of established medical protocols they do not fully understand," Turban said. "It is a recipe for unintended and dangerous medical consequences."

Follow NBC Out on Twitter, Facebook & Instagram

Tim Fitzsimons reports on LGBTQ news for NBC Out.

More here:
Mom of trans child pleads with lawmaker brother over trans health care bill - NBC News

The Testosterone Replacement Therapy Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Testosterone Replacement Therapy market report provides authentic and reliable estimates for the forecast period.

It became essential to distinguish the saturation of consumption in the Testosterone Replacement Therapy market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation analysis based on several segments such as types, applications, regions, and end-users. It serves to precise target the actual market size and product and service needs of customers. It also helps industry companies in promoting products that completely meet emerging customer needs.

Collect sample copy of the Testosterone Replacement Therapy market research at: https://www.amplemarketreports.com/sample-request/global-testosterone-replacement-therapy-market-1316861.html

The report furnishes the analysis of market encounter, segmentation, leading market players, industry environment, and microeconomic factors that help clients, Testosterone Replacement Therapy companies, investors, officials, and researchers perceive ongoing market performance within a minute. The report also reveals in-depth details of shifting market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting factors, and market variations that have been considered the most important factors in the Testosterone Replacement Therapy market.

Comprehensive analysis of Testosterone Replacement Therapy market segment by manufactures:

The report also highlights its financial position by assessing gross margin, profitability, production cost, pricing structure, expenses, Testosterone Replacement Therapy sales volume, revenue, and growth rate. Their raw material sourcing strategies, organizational structure, corporate alliance, Testosterone Replacement Therapy production volume, manufacturing base, sales areas, distribution network, global presence, product specifications, effective technologies, major vendors, and import-export activities are also emphasized in this report.

The report includes profound importance for the individuals/companies operating and financing in the Testosterone Replacement Therapy market as AbbVie, Teva, Pfizer, Endo International, Novartis, Eli lilly, Upsher-Smith, Bayer, Actavis (Allergan), Mylan, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals, it holds helpful insights that immediate to discover and interpret market demand, market size, share, and rivalry sitch. The report incorporates comprehensive market intelligence procured using both qualitative and quantitative research methods. It also contracts proficient systematic analytical studies including Porters Five Forces, SWOT analysis, and Probability analysis to review the market thoroughly.

Find out more about competitive landscape at: https://www.amplemarketreports.com/report/global-testosterone-replacement-therapy-market-1316861.html

The report moreover presents a comprehensive representation of Testosterone Replacement Therapy manufacturers and companies who have been attempting to pose their dominance in the market in terms of sales, revenue, and growth. The report traverses their applications such as product research, development, innovation, and technology appropriation which supports them deliver more efficient product lineup in the industry. Profitable business plans, including acquiring, mergers, ventures, amalgamations, as well as product launches, and brand promotions are also elucidating in the report.

Comprehensive analysis of Testosterone Replacement Therapy market segment Type, Application:

Furthermore, it explores various requisite segments of the global Testosterone Replacement Therapy market such as types, applications, regions, and technologies. The report grants a comprehensive analysis of each market acknowledging market acceptance, attractiveness, demand, production, and predicted sales revenue by Type(Gels, Injections, Patches, Other) and by Application(Gels, Injections, Patches, Other). The segmentation analysis helps consumers to select suitable segments for their Testosterone Replacement Therapy business and specifically target the wants and needs of their existing and potential customer base.

Comprehensive analysis of Testosterone Replacement Therapy market segment by Regional Anlaysis:

The report focuses on regional coverage across the globe principally with respect to x-x Units, revenue (Million USD), market share and growth rate variable with in each region depending upon its capacity. Regions that have been covered for this market included United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia

Discount, Know more this research report at: https://www.amplemarketreports.com/discount-request/global-testosterone-replacement-therapy-market-1316861.html

Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Western / Eastern Europe or Southeast Asia.

With the given market data, Research on Global Markets offers customizations according to specific needs. Write to AMR at sales@amplemarketreports.com, or connect via +1-530-868-6979

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to delivery reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: sales@amplemarketreports.com

https://www.amplemarketreports.com

Read more from the original source:
Global Testosterone Replacement Therapy Market Expected to Witness a Sustainable Growth over 2025 - Expedition 99

Page 78«..1020..77787980..90100..»

Home » Testosterone » Page 78